Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow-to-Debt Ratio
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow-to-Debt Ratio of 0.44x as of March 2026, meaning its operating cash flow of $59.59 Million could theoretically repay 0% of its total liabilities ($134.91 Million) in one year. Explore Catalyst Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Catalyst Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Catalyst Pharmaceuticals Inc across 22 annual periods. Also explore Catalyst Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Catalyst Pharmaceuticals Inc (2004–2025)
Year-by-year debt coverage analysis for Catalyst Pharmaceuticals Inc. For market capitalisation and broader financial context, see Catalyst Pharmaceuticals Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | $208.67 Million | $152.54 Million | ▼ -29.4% |
| 2024 | 1.94x | $239.81 Million | $123.78 Million | ▲ +10.9% |
| 2023 | 1.75x | $143.60 Million | $82.23 Million | ▲ +13.2% |
| 2022 | 1.54x | $116.05 Million | $75.21 Million | ▼ -20.9% |
| 2021 | 1.95x | $60.37 Million | $30.96 Million | ▼ -1.5% |
| 2020 | 1.98x | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.61 Million | $24.75 Million | ▲ +152.6% |
| 2018 | -2.66x | $-25.70 Million | $9.67 Million | ▲ +14.4% |
| 2017 | -3.11x | $-13.74 Million | $4.42 Million | ▲ +58.5% |
| 2016 | -7.49x | $-17.96 Million | $2.40 Million | ▼ -92.3% |
| 2015 | -3.89x | $-18.02 Million | $4.63 Million | ▼ -160.8% |
| 2014 | -1.49x | $-12.94 Million | $8.67 Million | ▲ +39.8% |
| 2013 | -2.48x | $-9.88 Million | $3.98 Million | ▼ -4.7% |
| 2012 | -2.37x | $-5.14 Million | $2.17 Million | ▼ -18.4% |
| 2011 | -2.00x | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.98x | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.05x | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $1.47 Million | ▲ +54.7% |
| 2007 | -12.39x | $-4.42 Million | $357.17K | ▼ -712.4% |
| 2006 | -1.52x | $-1.18 Million | $772.85K | ▼ -14.9% |
| 2005 | -1.33x | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.40x | $-230.52K | $67.80K | — |